ABvac-40

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameABvac-40
Drug Alias NameABvac-40
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsCognitive DysfunctionAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenItalyFrance +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAraclon Biotech Sl
China Registration ClassN/A

Develop Information

Active CompaniesAraclon Biotech Sl
Inactive CompaniesN/A
Active IndicationsCognitive DysfunctionAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A